MedTrace Logo

Effect of Oat Beta Glucan in Managing Blood Pressure

NCT05029427 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2023-01-26

No results posted yet for this study

Summary

This is a randomized, double-blinded, cross-over pilot study comparing the effects of ingesting oats containing high molecular weight β-glucan in reducing blood pressure.

Conditions

  • Elevated Blood Pressure

Interventions

OTHER

High molecular weight β-glucan oat cookies

Two cookies that contains 4g beta glucan made from oats will be consumed per day.

OTHER

Control wheat based cookies

Two cookies that made from cream of wheat without beta glucan will be consumed per day.

Sponsors & Collaborators

  • Agriculture and Agri-Food Canada

    collaborator OTHER_GOV

  • University of Manitoba

    lead OTHER

Principal Investigators

  • Dylan Mackay, PhD · University of Manitoba

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-28
Primary Completion
2022-12-14
Completion
2022-12-23

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05029427 on ClinicalTrials.gov